FDA Weighs Clinician-Style Tests for Generative AI Medical Devices

The FDA is exploring a regulatory framework for generative AI medical devices that assesses their clinical competence similarly to how physicians are evaluated, focusing on testing real-world performance and ongoing monitoring rather than every possible input-output scenario.

This Wire brief sits within Fusion42's coverage of Digital Health, and 14 sources have reported it between 18 Aug 2026 and 15 Sep 2026.